EP2317969A1 - Produit de traitement capillaire - Google Patents

Produit de traitement capillaire

Info

Publication number
EP2317969A1
EP2317969A1 EP09781408A EP09781408A EP2317969A1 EP 2317969 A1 EP2317969 A1 EP 2317969A1 EP 09781408 A EP09781408 A EP 09781408A EP 09781408 A EP09781408 A EP 09781408A EP 2317969 A1 EP2317969 A1 EP 2317969A1
Authority
EP
European Patent Office
Prior art keywords
oil
sodium
polyglyceryl
hydrogenated
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP09781408A
Other languages
German (de)
English (en)
Inventor
Erik Schulze Zur Wiesche
Thomas Förster
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel AG and Co KGaA
Original Assignee
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel AG and Co KGaA filed Critical Henkel AG and Co KGaA
Publication of EP2317969A1 publication Critical patent/EP2317969A1/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/463—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfuric acid derivatives, e.g. sodium lauryl sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair

Definitions

  • the present invention relates to hair treatment compositions containing highly effective combinations of surfactant (s), preservative (s) and oil body (s).
  • Human hair is today treated in a variety of ways with hair cosmetic preparations. These include, for example, the cleansing of hair with shampoos, the care and regeneration with rinses and cures and the bleaching, dyeing and shaping of the hair with dyes, tinting agents, waving agents and styling preparations.
  • active ingredients both for separate aftertreatment agents and for combination preparations generally have a preferential effect on the hair surface.
  • active ingredients are known which give the hair shine, hold, fullness, better wet or dry combabilities or prevent splitting.
  • the internal structural cohesion of the hair fibers which can be greatly influenced, in particular, by oxidative and reductive processes such as dyeing and perming.
  • the known active ingredients can not cover all needs sufficiently.
  • LOHAS is a marketing term that stands for "Lifestyle of Health and Sustainability” and defines a new lifestyle or consumer type that impacts on consumer health and health Sustainability oriented. It is an object of the present invention to provide hair treatment compositions which impart advantageous properties in terms of strength, feel and tensile strength as well as combability in the dry and wet state to the hair treated with them and which are particularly mild and ecologically compatible.
  • the subject matter of the present application is a hair treatment composition
  • a hair treatment composition comprising, in a cosmetically acceptable carrier,
  • the surfactant or surfactants (s) exclusively / come from the group of compounds with the following INCI names: ammonium coco sulphate, ammonium glycyrrhizate, ammonium lauryl sulfate, caprylic / capric triglycerides , Caprylyl Glycine, Carprylyl / Capryl Glucoside, Chitosan Glycolate, Chitosan Lactate, Chitosan PCA, Hydrogenated Apricot Kernel OiI, Hydrogenated Castor OiI, Hydrogenated Coco- Glycerides, Hydrogenated Coconut OiI, Hydrogenated Jojoba OiI, Hydrogenated Lecithin, Hydrogenated Meadowfoam Seed OiI, Hydrogenated Olive OiI, Hydrogenated Palm Glycerides, Hydrogenated Palm Glyceride Citrate, Lauryl Glucoside, Polyglyceryl-10 Laurate, Polyglyceryl
  • compositions according to the invention can be used as hair shampoos, hair conditioners, conditioning shampoos, as hairsprays, hair rinses, hair treatments, hair wraps, hair tonics, perming solutions, hair dye shampoos, hair dyes, hair fixatives, hair dressings, hairstyling preparations, eg Fönwell lotions, mousses, hair gels, Hair waxes and other hair cleansing and hair treatment products. They may be formulated as "leave-on” or "rinse-off" products on the hair, the latter being preferred.
  • compositions of the invention contain at least one surfactant, wherein all surfactants contained in the middle must come from the group of 40 substances mentioned and no surfactants may be included from other groups.
  • the surfactants contained in the compositions of the invention are based on coconut oil or coconut oil (Ammonium Coco-Sulfate, Sodium Coco-Sulfate, Hydrogenated Coco-Glycerides, Hydrogenated Coconut OiI, Sodium Coco-Glucoside Tartrate, Sodium Cocopolyglucose Tartrate, Sodium Cocoyl Alaninate, Sodium Cocoyl Amino Acids, sodium cocoyl glutamate) or sugars or other renewable raw materials such as palm kernel oil, etc.
  • compositions of the invention contain at least one preservative, wherein all preservatives contained in the middle must come from the group of the 13 substances mentioned and no preservatives from other groups may be included.
  • the preservatives contained in the compositions according to the invention are also accessible from natural sources.
  • An inventively particularly preferred preservative is ethanol of plant origin, which is obtained for example by fermentation from biomass.
  • the compositions according to the invention contain at least one oil body, wherein all the oil bodies contained in the middle must originate from the group of substances named 33 and no oil bodies from other groups may be contained.
  • the oil bodies contained in the agents according to the invention are also accessible from natural sources.
  • a preferred oil body which can be used according to the invention is amaranth seed oil.
  • a suitable oil according to the invention is available, for example, under the trade name "Amaranth Seed OiI” from the company Euro Ingredients.
  • argan oil is the oil of the seed of argan fruit.
  • a preferred oil body usable according to the invention is rice germ oil.
  • a preferred oil body usable according to the invention is baobab oil.
  • a preferred oil body usable according to the invention is Manetti oil.
  • the Atlas cedar (Cedrus atlantica) is a species of the genus of cedars (Cedrus) in the family of the pine family (Pinaceae).
  • a preferred oil body usable according to the invention is Marula seed oil.
  • a preferred oil body which can be used according to the invention is Yangus seed oil.
  • Yangu oil also known as Cape nut oil, is extracted from the seeds of the African Yangu tree.
  • a preferred oil body which can be used according to the invention is rambutan oil.
  • a preferred oil body which can be used according to the invention is Buckthorn oil, also known as buckthorn oil.
  • a preferred oil body usable according to the invention is Monoi de Tahiti.
  • Monoi Oil or Monoi Tiare de Tahiti is a traditional beauty product made in French Polynesia.
  • a preferred oil body which can be used according to the invention is Tigernut oil, also called Erdmandelöl.
  • a preferred oil body usable according to the invention is Inca Inchi oil.
  • compositions according to the invention contain at least one surfactant from the group mentioned, at least one preservative from the group mentioned and at least one oil body from the group mentioned.
  • Preferred agents of the invention contain specially selected ones
  • Agents which are particularly preferred according to the invention comprise at least one of those mentioned therein
  • the agents according to the invention contain the abovementioned substances in a cosmetically acceptable carrier. Preferably, this contains as little petrochemical based
  • Preferred hair treatment compositions according to the invention are characterized in that they do not contain compounds of the formula (I)
  • n stands for integers between 1 and 100,000.
  • the omission of compounds of the formula (I) means that the combination of active ingredients has a significantly better effect on the hair.
  • the strengthening of the keratinic fibers which manifests itself in improved combing in the dry and especially in the wet state, and the fullness and smoothness are improved.
  • the agents according to the invention are not only free of polyethylene glycols but also of polypropylene glycols (PPG).
  • Hair treatment compositions preferred according to the invention are characterized in that they do not contain compounds of the formula (II)
  • n stands for integers between 1 and 100,000.
  • nonionic surfactants of the alkyl or alkenyl ethoxylate type also reduce the positive effects of the agents according to the invention and should therefore not be used in the formulations.
  • Further preferred hair treatment agents according to the invention are therefore characterized in that they do not contain compounds of the formula (INI)
  • Ethoxylated anionic surfactants can also - albeit to a lesser extent - reduce the positive effect.
  • alkyl ether sulfates have been found to be problematic here, while alkyl ether carboxylates show less effect-reducing effects than the ether sulfates.
  • Preferred hair treatment compositions according to the invention therefore contain no compounds of the formula (IV)
  • R is any alkyl or alkenyl radical and n is an integer between 1 and 10,000.
  • a hydroxyethyl moiety eg, in certain surfactants
  • Particularly preferred hair treatment compositions according to the invention are characterized in that they contain no compounds which contain the grouping of the formula (V)
  • n is an integer between 2 and 100,000.
  • According to particularly preferred means additionally contain a fruit and / or vegetable juice.
  • Agents preferred according to the invention comprise at least one fruit juice, this being preferably used within narrower ranges of amounts.
  • Hair treatment agents which are preferred according to the invention are characterized in that they contain, based on their weight, from 20 to 80% by weight, preferably from 25 to 75% by weight, more preferably from 30 to 70% by weight and in particular from 35 to 60% by weight. contain at least one fruit juice.
  • Fruit juice (fruit juice) in the sense of the present invention is the fermentable, but not fermented juice obtained from fruits by means of mechanical methods. Equally juxtaposed with these fruit juices are concentrated fruit juices obtained by adding concentrated water (in the form of water of appropriate quality) and the separated volatile flavorings to reconstituted juices (so-called reconstituted fruit juices). The pulp separated in the concentration of the original fruit juice or juices of the same fruit type may be added to the reconstituted fruit juice up to the amount contained in the original juice.
  • Fruit juices are either produced directly from fresh fruit as "juice” and bottled or obtained from semi-finished products, such as fruit juice concentrates or from pulp-containing fruit pulp or fruit pulp concentrates.
  • semi-finished products such as fruit juice concentrates or from pulp-containing fruit pulp or fruit pulp concentrates.
  • the production of fruit juice from concentrate is especially important for orange juices. They are concentrated in the producer country and rediluted in the consumer country.
  • hair-treatment compositions according to the invention are preferred which contain at least one fruit juice from the group of apple juice, orange juice, grape juice, lemon juice, lime juice, lime juice, grapefruit juice, currant juice, cherry juice, shadow morel juice, apricot juice, peach juice, nectarine juice, plum juice, mirabelle juice, passion fruit juice, plum juice, puree raspberry juice, blackberry juice , Raspberry juice, strawberry juice, pineapple juice, pomegranate juice, lychee juice, mango juice, tangerine juice, papaya juice, pitahaya juice, star fruit juice, pear juice, quince juice, medlar juice, Savory juice, rowan juice, gooseberry juice, blueberry juice, cranberry juice, tayberry juice, cranberry juice, elderberry juice, apple juice, sea buckthorn juice included.
  • Hair-treatment compositions according to the invention which contain fruit and / or vegetable juices from controlled organic cultivation are therefore particularly preferred.
  • the agents according to the invention contain the abovementioned substances in a cosmetically acceptable carrier.
  • This may contain various solvents, preference being given to hair treatment compositions according to the invention which are exclusively solvents from the group
  • Ethanol (alcohol) of vegetable origin fats and oils of vegetable origin glycerin from fats and oils of vegetable origin containing water.
  • compositions according to the invention may furthermore contain all ingredients customary for cosmetic compositions, for example those from the groups of nonionic polymers, such as vinylpyrrolidone / vinyl acrylate copolymers, for example.
  • Thickeners such as agar-agar, guar gum, alginates, xanthan gum, gum arabic,
  • Derivatives such as amylose, amylopectin and dextrins, clays such. B. bentonite or fully synthetic
  • Hydrocolloids such as polyvinyl alcohol, hair conditioning compounds such as phospholipids, such as soybean lecithin, egg lecithin and cephalins, and silicone oils,
  • Solvents and mediators such as ethanol, isopropanol, ethylene glycol, propylene glycol, glycerol and diethylene glycol, symmetrical and unsymmetrical, linear and branched dialkyl ethers having a total of from 12 to 36 carbon atoms, in particular 12 to 24 carbon atoms, such as di-n-octyl ether , Di-n-decyl ether, di-n-nonyl ether, di-n-undecyl ether and di-n-dodecyl ether, n-hexyl n-octyl ether, n-octyl n-decyl ether, n-decyl n-undecyl ether, n Undecyl-n-dodecyl ether and n-
  • Fatty alcohols in particular linear and / or saturated fatty alcohols having 8 to 30 carbon atoms,
  • Monoesters of C8 to C30 - fatty acids with alcohols having 6 to 24 carbon atoms fiber structure-improving agents, especially mono-, di- and oligosaccharides, such as glucose, galactose, fructose, fructose and lactose, Conditioning agents such as paraffin oils, vegetable oils, eg. Sunflower oil, orange oil,
  • Phospholipids for example soya lecithin, egg lecithin and cephalins, quaternized amines such as methyl-1-alkylamidoethyl-2-alkylimidazolinium methosulfate,
  • Anti-dandruff agents such as Piroctone Olamine, Zinc Omadine and Climbazole,
  • Active ingredients such as allantoin and bisabolol,
  • Bodying agents such as sugar esters, polyol esters or polyol alkyl ethers,
  • Fats and waxes such as spermaceti, beeswax, montan wax and paraffins,
  • Opacifiers such as latex, styrene / PVP and styrene / acrylamide copolymers
  • Pearlescing agents such as ethylene glycol mono- and distearate and PEG-3-distearate,
  • Reducing agents such as B. thioglycolic acid and its derivatives, thiolactic acid, cysteamine,
  • Propellants such as propane-butane mixtures, N 2 O, dimethyl ether, CO 2 and air,
  • Antioxidants contain. However, particular preference is given to dispensing with the use of synthetic substances, and agents of this preferred embodiment contain, in addition to the already mentioned substances from the groups of surfactants, preservatives, oil bodies and solvents exclusively natural ingredients. Particularly preferred hair treatment compositions according to the invention are therefore characterized in that they contain exclusively natural ingredients in addition to the substances already mentioned.
  • compositions according to the invention can be further enhanced by using certain care substances.
  • these are selected from certain groups of known care substances, since these care substances harmonize perfectly in terms of formulation and the care effect with the active ingredient combination used according to the invention.
  • Hair treatment compositions which are preferred according to the invention are characterized in that they additionally contain care substances (e), based on their weight, in amounts of from 0.001 to 10% by weight, preferably from 0.005 to 7.5% by weight, particularly preferably from 0.01 to 5 Wt .-% and in particular 0.05 to 2.5 wt .-%, with preferred care substance (s) are selected from the group i. L-carnitine and / or its salts; ii. Panthenol and / or panthothenic acid; iii. the 2-furanones and / or their derivatives, in particular pantolactone; iv. Taurine and / or its salts; v. niacinamide; vi. Ubiquinone vii. Ectoin; viii. Allantoin.
  • the active ingredient combination is combined with at least one care substance which is selected from L-carnitine and / or its salts, panthenol and / or pantothenic acid, 2-furanones and / or their derivatives, in particular pantolactone, taurine and / or its Salts, niacinamide, ubiquinones, ectoine, allantoin.
  • care substance which is selected from L-carnitine and / or its salts, panthenol and / or pantothenic acid, 2-furanones and / or their derivatives, in particular pantolactone, taurine and / or its Salts, niacinamide, ubiquinones, ectoine, allantoin.
  • care substance which is selected from L-carnitine and / or its salts, panthenol and / or pantothenic acid, 2-furanones and / or their derivatives, in particular pantolactone, taurine and / or its Salts, n
  • L-carnitine can form addition compounds and double salts.
  • L-carnitine derivatives which are preferred according to the invention are in particular selected from acetyl-L-carnitine, L-carnitine fumarate, L-carnitine citrate, lauroyl-L-carnitine and particularly preferably L-carnitine tartrate.
  • the L-carnitine compounds mentioned are available, for example, from Lonza GmbH (Wuppertal, Germany).
  • Preferred hair treatment compositions according to the invention are characterized in that they contain from -0.001 to 10% by weight, preferably 0.005 to 7.5% by weight, particularly preferably 0.01 to 5% by weight and in particular 0.05% by weight contain up to 2.5 wt .-% L-carnitine or L-carnitine derivatives, preferred L-carnitine derivatives are selected from acetyl-L-carnitine, L-carnitine fumarate, L-carnitine citrate, lauroyl-L-carnitine and in particular L-carnitine tartrate.
  • Panthenol (ILJPAC name: (+) - (R) -2,4-dihydroxy-N- (3-hydroxypropyl) -3,3-dimethylbutyramide) is converted to pantothenic acid in the body.
  • Pantothenic acid is a vitamin from the group of B vitamins (vitamin B5).
  • Preferred hair treatment compositions according to the invention are characterized in that they contain, based on their weight, from 0.01 to 5% by weight, preferably from 0.05 to 2.5% by weight, particularly preferably from 0.1 to 1.5% by weight. % and in particular 0.25 to 1 wt .-% panthenol (( ⁇ ) -2,4-dihydroxy- ⁇ / - (3-hydroxypropyl) -3,3-dimethyl-butyramide).
  • preferred hair treatment compositions contain - based on their weight - 0.01 to 15 wt .-%, preferably 0.025 to 12.5 wt .-%, particularly preferably 0.05 to 10 wt .-%, more preferably 0.1 to 7 , 5% by weight and in particular 0.5 to 5% by weight of at least one 2-furanone derivative of the formula (Fur-I) and / or of the formula (Fur-II) in which the radicals R 1 to R 10 are independently of one another
  • R 11 as a -C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, -C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear Mono-, di- or trihydroxyhydrocarbyl radical,
  • R 12 and R 13 each independently represent hydrogen, a methyl, a C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear mono-, di- or trihydroxyhydrocarbyl radical,
  • R 14 is hydrogen, a methyl, a C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C 2 -C 4 -saturated hydrocarbon radical, or diunsaturated, branched or linear mono-, di- or trihydroxyhydrocarbon hydrocarbon radical, a -C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear mono-, di- or triaminocarbyl radical,
  • R 15 and R 16 each represent hydrogen, methyl, a -C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C 2 -C 4 - saturated mono- or diunsaturated, branched or linear mono-, di- or trihydroxyhydrocarbyl radical, a -C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear mono-, di- or triaminocarbon radical, a group -COR 16 , wherein R 16 is a methyl, a C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C 2 -C 4 -saturated or -or- or a diunsaturated, branched or linear mono-, di- or trihydroxy hydrocarbon radical, a -C 2 -C 4
  • R 17 is a methyl, a -C 2 -C 30 -saturated or mono- or polyunsaturated, branched or linear hydrocarbon radical, a -C 2 -C 30 - saturated or on or - polyunsaturated, branched or linear mono-, di-, tri- or Polyhydroxykohlenwasserstoffrest, a -C 2 - C 30 - saturated or mono- or polyunsaturated, branched or linear mono-, di-, tri- or polyamino hydrocarbon radical, with the proviso in that, when R 7 and R 8 are -OH and at the same time R 9 or R 10 is hydrogen, the remaining group R 9 or R 10 does not represent a dihydroxyethyl radical.
  • Preferred compounds of the formula (fur-I) and / or of the formula (fur-II) can be compounds in which the substituents R 1 , R 2 and R 7 independently of one another represent:
  • R 11 as a -C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, -C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear Mono-, di- or trihydroxy-hydrocarbon radical, a group -NR 12 R 13 , where R 12 and R 13 each independently represent hydrogen, a methyl, a C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear mono-, di- or trihydroxy hydrocarbon radical,
  • R 14 is hydrogen, a methyl, a C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C 2 -C 4 -saturated or - or diunsaturated, branched or linear mono-, di- or trihydroxy hydrocarbon radical, a -C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear mono-, di- or triaminocarbon radical, a group -COR 16 , wherein R 16 is a methyl, a C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C 2 -C 4 -saturated or -or- or diunsaturated, branched or linear mono, di-trihydroxy hydrocarbon radical, a -C 2 -C 4 -saturated or mono- or diuns
  • R 17 is a methyl, a -C 2 -C 30 -saturated or mono- or polyunsaturated, branched or linear hydrocarbon radical, a - C 2 - C 30 - saturated or on or - polyunsaturated, branched or linear mono-, di-, tri- or polyhydroxyalkyl radical, or a -C 2 - C 30 - saturated or mono- or polyunsaturated, branched or linear mono-, di-, tri- or polyamino hydrocarbon radical.
  • Hydrogen an -OH, a methyl, methoxy, aminomethyl, hydroxymethyl radical, a -C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear mono-, di- or trihydroxy-hydrocarbon radical or a -C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear mono-, di- or triaminocarbon radical.
  • radicals R 5 , R 6 , R 9 and R 10 in the active substance according to the formula (I) and / or formula (II) according to the invention may stand independently of one another for:
  • a compound of the formula (Fur-I) is used. It may be preferred that in a compound of the formula (fur-I), the radicals R 1 and R 2 are independently of one another:
  • Mono-, di- or trihydroxyhydrocarbyl radical a group -OR 11 , with R 11 as a -C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, -C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear Mono-, di- or trihydroxyhydrocarbyl radical,
  • R 14 is hydrogen, a methyl, a C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C 2 -C 4 -saturated hydrocarbon radical, or diunsaturated, branched or linear mono-, di- or trihydroxyhydrocarbyl radical,
  • R 16 is a methyl, a C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C 2 -C 4 -saturated or -or- or diunsaturated, branched or linear mono, di-trihydroxy hydrocarbon radical,
  • R 17 is a methyl, a -C 2 -C 30 -saturated or mono- or polyunsaturated, branched or linear hydrocarbon radical, a - C 2 - C 30 - saturated or on or - polyunsaturated, branched or linear mono-, di-, tri- or Polyhydroxykohlenwasserstoffrest.
  • the compounds of the formula (Fur I) for the radicals R 5 and R 6 may stand independently for: a C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear Mono-, di- or trihydroxyhydrocarbyl radical, a group -OR 11 , with R 11 as a -C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, -C 2 -C 4 -saturated or mono- or diunsaturated, branched or linear mono , Di- or trihydroxyhydrocarbyl radical.
  • preferred hair treatment compositions contain - based on their weight - 0.01 to 15 wt .-%, preferably 0.025 to 12.5 wt .-%, particularly preferably 0.05 to 10 wt .-%, more preferably 0.1 to 7 , 5 wt .-% and in particular 0.5 to 5 wt .-% taurine (2-aminoethanesulfonic acid).
  • vitamin A includes retinol (vitamin A 1 ) and 3,4-didehydroretinol (vitamin A 2 ).
  • the ß-carotene is the provitamin of retinol.
  • vitamin A component according to the invention for example, vitamin A acid and its esters, vitamin A aldehyde and vitamin A alcohol and its esters such as the palmitate and the acetate into consideration.
  • the agents according to the invention preferably contain the vitamin A component in amounts of 0.05-1% by weight, based on the total preparation.
  • the vitamin B group or the vitamin B complex include vitamin B 1 (thiamine) vitamin B 2 (riboflavin) Vitamin B 3 .
  • Vitamin B 1 thiamine
  • vitamin B 2 riboflavin
  • Vitamin B 3 Vitamin B 1
  • the compounds nicotinic acid and nicotinamide (niacinamide) are often performed.
  • Preferred according to the invention is the nicotinic acid amide which is contained in the agents used according to the invention preferably in amounts of from 0.05 to 1% by weight, based on the total agent.
  • Vitamin B 5 pantothenic acid, panthenol and pantolactone.
  • Panthenol and / or pantolactone are preferably used in the context of this group (see below).
  • Derivatives of panthenol which can be used according to the invention are, in particular, the esters and ethers of panthenol and also cationically derivatized panthenols. Individual representatives are, for example, the panthenol triacetate, the panthenol monoethyl ether and its monoacetate and also the cationic panthenol derivatives disclosed in WO 92/13829.
  • the said compounds of the vitamin B 5 type are preferably contained in the agents according to the invention in amounts of 0.05-10% by weight, based on the total agent. Amounts of 0.1-5 wt .-% are particularly preferred. Vitamin B 6 (pyridoxine and pyridoxamine and pyridoxal).
  • Vitamin C (ascorbic acid). Vitamin C is used in the agents according to the invention preferably in amounts of 0.1 to 3 wt .-%, based on the total agent. Use in the form of palmitic acid ester, glucosides or phosphates may be preferred. The use in combination with tocopherols may also be preferred.
  • Vitamin E tocopherols, especially ⁇ -tocopherol.
  • Tocopherol and its derivatives which include in particular the esters such as the acetate, the nicotinate, the phosphate and the succinate, are preferably present in the agents according to the invention in amounts of 0.05-1% by weight, based on the total agent.
  • Vitamin F is usually understood as meaning essential fatty acids, in particular linoleic acid, linolenic acid and arachidonic acid.
  • Vitamin H is the compound (3aS, 4S, 6aR) -2-oxohexahydrothienol [3,4-cf] - imidazole-4-valeric acid, for which, however, the trivial name biotin has meanwhile prevailed.
  • Biotin is preferably present in the compositions according to the invention in amounts of from 0.0001 to 1.0% by weight, in particular in amounts of from 0.001 to 0.01% by weight.
  • hair-treatment compositions according to the invention are preferred which, based on their weight, are 0.1 to 5% by weight, preferably 0.2 to 4% by weight, more preferably 0.25 to 3.5% by weight, more preferably Contain 0.5 to 3 wt .-% and in particular 0.5 to 2.5 wt .-% vitamins and / or pro-vitamins and / or vitamin precursors, preferably the groups A, B, C, E, F and H.
  • compositions according to the invention can therefore contain from 0.0001 to 5% by weight of at least one biochinone of the formula (Ubi)
  • X, Y, Z are independently -O- or -NH- or NR- or a chemical bond
  • R 1 , R 2 , R 3 independently of one another represent a hydrogen atom or an optionally substituted aryl group or an optionally substituted (C 1 -C 6 ) -alkyl group or a hydroxyalkyl group or a polyhydroxyalkyl group or an optionally substituted (C 1 -Ce) - Alkylene group, or a (C-rC 6 ) acyl radical, wherein preferred radicals are independently selected from -H, CH 3 , -CH 2 CH 3 , - (CH 2 ) 2 CH 2 , -CH (CH 3 ) 2 , - (CH 2 ) 3 CH 3 , -CH (CH 3 ) CH 2 CH 3 , - CH 2 CH (CH 3 ) 2 , -C (CH 3 ) 3
  • R 4 is -CH 3 , -CH 2 CH 3 , - (CH 2 ) 2 CH 2 , -CH (CH 3 ) 2 ,
  • (CH 2 ) 3 CH 3 , -CH (CH 3 ) CH 2 CH 3 , -CH 2 CH (CH 3 ) 2 , -C (CH 3 ) 3 n is from 1 to 20, preferably from 2 to 15 and in particular for 5, 6, 7, 8, 9, 10.
  • Preferred compounds of the formula (Ubi) according to the invention are, for example
  • R 1 , R 2 , R 3 each independently represent -H
  • R 4 is -CH 3 , or -CH 2 CH 3 , or - (CH 2 ) 2 CH 2 , or -CH (CH 3 ) 2 n is from 1 to 20, preferably from 2 to 15 and especially for 5, 6, 7, 8, 9, 10.
  • Particularly preferred hair treatment compositions according to the invention are characterized in that they contain as care substance - based on their weight - 0.0001 to 1 wt .-%, preferably 0.001 to 0.5 wt .-% and particularly preferably 0.005 to 0.1 wt .-% containing at least one ubiquinone and / or at least one ubiquinol and / or at least one derivative of these substances, preferred agents containing a ubiquinone of the formula (Ubi)
  • n 6, 7, 8, 9 or 10, particularly preferably 10 (coenzyme Q10).
  • the agents according to the invention may also contain plastoquinones.
  • preferred agents according to the invention are characterized in that they are 0.0002 to 4 wt .-%, preferably 0.0005 to 3 wt .-%, particularly preferably 0.001 to 2 wt .-%, more preferably 0.0015 to 1 and in particular 0.002 to 0.5 wt .-% of at least one plastoquinone of the formula (Ubi-b)
  • n stands for values of 1 to 20, preferably of 2 to 15 and in particular for 5, 6, 7, 8, 9, 10, whereby particularly preferred means Plastochinon PQ-9 of the formula
  • the agents according to the invention may contain ectoin.
  • Ectoine ((4S) - 2-methyl-1, 4,5,6-tetrahydropyrimidine-4-carboxylic acid) is a natural product belonging to the group of compatible solutes.
  • the highly water-binding low molecular weight organic compound occurs in halophilic bacteria and allows these extremophilic organisms under Survive stress conditions.
  • Hair treatment compositions which are preferred according to the invention are characterized in that they contain, based on their weight, from 0.001 to 10% by weight, preferably from 0.01 to 5% by weight, particularly preferably from 0.05 to 2.5% by weight and in particular from 0 , 1 to 1% by weight of (S) -2-methyl-1, 4,5,6-tetrahydro-4-pyrimidinecarboxylic acid (ectoine) and the physiologically tolerated salts of this compound and / or (S, S) -5- Hydroxy-2-methyl-1, 4,5,6-tetrahydro-4-pyrimidinecarboxylic acid (hydroxyectoine) and the physiologically acceptable salts of this compound.
  • S -2-methyl-1, 4,5,6-tetrahydro-4-pyrimidinecarboxylic acid
  • hydroxyectoine hydroxyectoine
  • Allantoin (5-ureidohydantoin, ⁇ / - (2,5-dioxo-4-imidazolidinyl) urea) is the final product of nucleic acid degradation, especially of purine, in various animal species, especially mammals, in addition to uric acid.
  • particularly preferred hair treatment compositions contain, based on their weight, from 0.001 to 10% by weight, preferably from 0.01 to 5% by weight, particularly preferably from 0.05 to 2.5% by weight and in particular from 0.1 to 1 5% ureidohydantoin (allantoin).
  • compositions according to the invention may contain purine and / or purine derivatives as a care substance.
  • purine and / or purine derivatives with ubiquinones and / or plastoquinones as a care substance means that the hairs treated with appropriate agents show, inter alia, higher measured values in differential thermal analysis and improved wet and dry combabilities.
  • Preferred agents according to the invention contain purine and / or purine derivatives in narrower quantitative ranges.
  • inventively preferred cosmetic agents characterized in that they - based on their weight - 0.001 to 2.5 wt .-%, preferably 0.0025 to 1 wt .-%, particularly preferably 0.005 to 0.5 wt .-% and in particular from 0.01 to 0.1% by weight of purine (s) and / or purine derivative (s).
  • Hair treatment compositions which are preferred according to the invention are characterized in that they contain as care substance - based on their weight - from 0.001 to 2.5% by weight, preferably from 0.0025 to 1% by weight, particularly preferably from 0.005 to 0.5% by weight and in particular from 0.01 to 0.1% by weight of purine (s) and / or purine derivative (s), preferred agents containing purine and / or purine derivative (s) of formula (Pur-I)
  • agents according to the invention are preferred in which the weight ratio of purine (derivative (s)) and biochinone (s) is 10: 1 to 1: 100, preferably 5: 1 to 1:50, particularly preferably 2: 1 to 1:20 and in particular 1: 1 to 1:10.
  • caffeine is a particularly preferred purine derivative
  • coenzyme Q10 is a particularly preferred biochinone.
  • Particularly preferred agents according to the invention are therefore characterized in that they contain, based on their weight, from 0.001 to 2.5% by weight, preferably from 0.0025 to 1% by weight, particularly preferably from 0.005 to 0.5% by weight and in particular 0.01 to 0.1 wt .-% caffeine and 0.0002 to 4 wt .-%, preferably 0.0005 to 3 wt .-%, particularly preferably 0.001 to 2 wt .-%, more preferably 0.0015 to 1 and in particular 0.002 to 0.5 wt .-% coenzyme Q10 included.
  • the compositions of the invention may also contain flavonoids.
  • the flavonoids are a group of water-soluble plant dyes and play an important role in the metabolism of many plants. They belong together with the phenolic acids to the polyphenols. There are well over 6500 different flavonoids known, which can be divided into flavonols, flavones, flavanones, isoflavonoids and anthocyanins.
  • flavonoids from all six groups can be used, with certain representatives from the individual groups are preferred as a care substance because of their particularly intense action.
  • Preferred flavonols are quercetin, rutin, kaempferol, myricetin, isorhamnetin, preferred flavanols are catechin, gallocatechin, epicatechin, epigallocatechin gallate, theaflavin, thearubigin, preferred flavones are luteolin, apigenin, morin, preferred flavanones are hesperetin, naringenin, eriodictyol, preferred isoflavonoids are genistein , Daidzein, and preferred anthocyanidins (anthocyanins) are cyanidin, delphinidin, malvidin, pelargonidin, peonidin, petunidin.
  • particularly preferred hair treatment compositions are characterized in that they - based on their weight - 0.001 to 2.5 wt .-%, preferably 0.0025 to 1 wt .-%, particularly preferably 0.005 to 0.5 wt .-% and in particular 0.01 to 0.1% by weight of flavonoids, in particular flavonols, more preferably 3,3 ', 4', 5,7-pentahydroxyflavone (quercetin) and / or 3,3 ', 4', 5,7-pentahydroxyflavone -3-O-rutinoside (rutin), included.
  • flavonoids in particular flavonols, more preferably 3,3 ', 4', 5,7-pentahydroxyflavone (quercetin) and / or 3,3 ', 4', 5,7-pentahydroxyflavone -3-O-rutinoside (rutin), included.
  • hair treatment compositions according to the invention which additionally contain 0.001 to 5 wt .-%, preferably 0.01 to 4 wt .-%, particularly preferably 0.02 to 2.5 wt .-% and in particular 0.1 to 1, 5 wt % Bisabolol and / or oxides of bisabolol, preferably (-) - alpha-bisabolol.
  • Creatine is also suitable as a care substance according to the invention.
  • Creatine (3-methylguanidinoacetic acid) is an organic acid found in vertebrates and the like. a. contributes to supplying the muscles with energy. Creatine is synthesized in the kidney, liver and pancreas. It is formally derived from the amino acids glycine and arginine and is 95% present in skeletal muscle.
  • Particularly preferred hair treatment compositions according to the invention contain - based on their weight - 0.01 to 15 wt .-%, preferably 0.025 to 12.5 wt .-%, particularly preferably 0.05 to 10 wt .-%, more preferably 0.1 to 7.5 wt .-% and in particular 0.5 to 5 wt .-% ⁇ / -methyl-guanidino-acetic acid (creatine).
  • the agents according to the invention may contain further care substances. Their presence is not absolutely necessary for achieving the effects according to the invention, but further effects, such as a pleasant touch or a pleasant application feel, can result from the use of these care substances.
  • the agents according to the invention may with particular preference contain one or more amino acids.
  • Amino acids which can be used particularly preferably according to the invention are selected from the group consisting of glycine, alanine, VaNn, leucine, isoleucine, phenylalanine, tyrosine, tryptophan, proline, aspartic acid, glutamic acid, asparagine, glutamine, serine, threonine, cysteine, methionine, lysine, arginine, histidine, ⁇ Alanine, 4-aminobutyric acid (GABA), betaine, L-cystine (L-Cyss), L-carnitine, L-citrulline, L-theanine, 3 ', 4'-dihydroxy-L-phenylalanine (L-dopa), 5'-hydroxy-L-tryptophan, L-homocysteine, S-methyl-L-methionine, S-ally
  • Preferred agents according to the invention contain one or more amino acids in narrower quantitative ranges.
  • preferred hair treatment compositions are characterized in that they as care substance - based on their weight - 0.01 to 5 wt .-%, preferably 0.02 to 2.5 wt .-%, particularly preferably 0.05 to 1, 5 Wt .-%, more preferably 0.075 to 1 wt .-% and in particular 0.1 to 0.25 wt .-% amino acid (s), preferably from the group of glycine and / or alanine and / or valine and / or lysine and / or leucine and / or threonine.
  • the agents according to the invention may contain at least one carbohydrate from the group of monosaccharides, disaccharides and / or oligosaccharides.
  • preferred hair treatment compositions according to the invention characterized in that they are used as care substance - based on their weight - 0.01 to 5 wt .-%, preferably 0.05 to 4.5 wt .-%, particularly preferably 0.1 to 4 wt. -%, more preferably 0.5 to 3.5 wt .-% and in particular 0.75 to 2.5 wt .-% carbohydrate (s) selected from monosaccharides, disaccharides and / or oligosaccharides containing preferred carbohydrates are selected out
  • Monosaccharides in particular D-ribose and / or, D-xylose and / or L-arabinose and / or D-glucose and / or D-mannose and / or D-galactose and / or D-fructose and / or sorbose and / or L-fucose and / or L-rhamnose disaccharides, in particular sucrose and / or maltose and / or lactose and / or trehalose and / or cellobiose and / or gentiobiose and / or isomaltose.
  • Particularly preferred agents according to the invention contain based on their weight
  • preferred agents according to the invention contain (a) amino acid (s).
  • Preferred agents according to the invention contain one or more amino acids in narrower quantitative ranges.
  • preferred cosmetic agents are characterized in that they additionally contain from 0.05 to 5% by weight, preferably from 0.1 to 2.5% by weight, more preferably from 0.15 to 1% by weight and in particular from 0 , 2 to 0.5 wt .-% amino acid (s), preferably (one) amino acid (s) from the group glycine and / or alanine and / or valine and / or lysine and / or leucine and / or threonine.
  • Particularly preferred agents according to the invention contain based on their weight
  • the abovementioned substances are preferably of natural origin, i. not synthetically manufactured or modified.
  • Especially preferred hair treatment compositions according to the invention contain, apart from the surfactants, preservatives, oil bodies and solvents mentioned, only ingredients from a limited group of natural substances.
  • Such hair treatment compositions according to the invention are characterized in that, in addition to the substances already mentioned, they contain exclusively substances from the group of compounds with the following INCI names: alginic acid, aluminum hydroxides, aluminum stearates, ammonium aluminum, anhydroxylitol, arginines, ascorbic acid, Ascorbyl Dipalmitate, Ascorbyl Palmitate, Behenyl Alcohol, Behenyl Beeswax, Brassica Campestris / Aleurites Fordi OiI Copolymer, C12-20 Alkyl Glucoside, C14-22 Alcohols, Calcium Alginate, Calcium Glycerophosphate, Calcium Lactate, Ceramide, Cetearyl Alcohol, Cetearyl Glucoside, Cetyl Alcohol , Cetyl Palmitate, Cetyl Ricinoleate, Cholesteryl Hydroxy

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cosmetics (AREA)

Abstract

Produit de traitement capillaire, contenant dans un support cosmétiquement acceptable - au moins un tensioactif, au moins un agent conservateur et au moins un corps huileux, le ou les tensioactifs provenant exclusivement du groupe des composés ayant les désignation INCI suivantes : Ammonium Coco-Sulfate, Ammonium Glycyrrhizate, Ammonium Lauryl Sulfate, Caprylic/Capric Triglyceride, Capryloyl Glycine, Carprylyl/Capryl Glucoside, Chitosan Glycolate, Chitosan Lactate, Chitosan PCA, Hydrogenated Apricot Kernel Oil, Hydrogenated Castor Oil, Hydrogenated Coco-Glycerides, Hydrogenated Coconut Oil, Hydrogenated Jojoba Oil, Hydrogenated Lecithin, Hydrogenated Meadowfoam Seed Oil, Hydrogenated Olive Oil, Hydrogenated Palm Glycerides, Hydrogenated Palm Glycerides Citrate, Lauryl Glucoside, Polyglyceryl-10 Laurate, Polyglyceryl-2 Dipolyhydroxystearate, Polyglyceryl-2 Polyhydroxystearate, Polyglyceryl-3 Caprylate, Polyglyceryl-3 Laurate, Polyglyceryl-3 Methylglucose Distearate, Polyglyceryl-3 Oleate, Polyglyceryl-3 Palmitate, Polyglyceryl-3 Polyricinoleate, Polyglyceryl-3 Ricinoleate, Polyglyceryl-5 Laurate, Polyglyceryl-6 Dicaprate, Polyglyceryl-6 Oleate, Polyglyceryl-6 Stearate, Sodium Coco-Glucoside Tartrate, Sodium Cocopolyglucose Tartrate, Sodium Coco-Sulfate, Sodium Cocoyl Alaninate, Sodium Cocoyl Amino Acids, Sodium Cocoyl Glutamate; le ou les agents conservateurs provenant exclusivement du groupe acide formique, formiates, acide benzoïque, benzoates, ester éthylique d'acide benzoïque, alcool benzylique, acide propionique, propionates, acide salicylique, salicylates, acide sorbique, sorbates, éthanol de provenance végétale; la ou les huiles provenant exclusivement du groupe huile de graines d'amaranthe, huile d'argan, huile de germe de riz, huile de baobab, huile de Manetti, huile d'amandes de marula, huile de Yangu, huile de ramboutan, huile de nerprun purgatif, monoï de Tahiti, huile de noix tigrée, huile d'Inca Inchi, huile d'avocat, huile de graines de coton, beurre de cupuaçu, huile de cajou, huile de chardon, huile d'arachide, huile de jojoba, huile de coco, huile de graine de courge, huile de lin, huile de macadamia, huile de germe de maïs, huile d'amandes, huile d'amandes d'abricot, huile de pavot, huile d'onagre, huile d'olive, huile de colza, huile de soja, huile de tournesol, huile de germe de blé.
EP09781408A 2008-09-08 2009-08-03 Produit de traitement capillaire Ceased EP2317969A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE200810046207 DE102008046207A1 (de) 2008-09-08 2008-09-08 Natürliches Haarbehandlungsmittel
PCT/EP2009/060014 WO2010026009A1 (fr) 2008-09-06 2009-08-03 Produit de traitement capillaire

Publications (1)

Publication Number Publication Date
EP2317969A1 true EP2317969A1 (fr) 2011-05-11

Family

ID=41168673

Family Applications (1)

Application Number Title Priority Date Filing Date
EP09781408A Ceased EP2317969A1 (fr) 2008-09-08 2009-08-03 Produit de traitement capillaire

Country Status (3)

Country Link
EP (1) EP2317969A1 (fr)
DE (1) DE102008046207A1 (fr)
WO (1) WO2010026009A1 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009028538A1 (de) * 2009-08-14 2011-02-17 Henkel Ag & Co. Kgaa Zusammensetzungen zur Haarpflege enthaltend Rambutanöl
DE102010002863A1 (de) * 2010-03-15 2011-09-15 Henkel Ag & Co. Kgaa Haarbehandlungsmittel mit mindestens vier ausgewählten Ölen
US9265321B2 (en) 2010-03-19 2016-02-23 Kao Corporation Hair care products containing conjugated unsaturated oils
KR20140069279A (ko) * 2011-09-30 2014-06-09 이엘씨 매니지먼트 엘엘씨 실리콘 유화제-비함유 천연 유화제계를 갖는 개인 조성물
EP2609907A1 (fr) * 2011-12-27 2013-07-03 KPSS-Kao Professional Salon Services GmbH Composition de coloration capillaire comprenant de l'huile de graine sclerocarya birrea
CN103393565B (zh) * 2013-07-20 2015-03-11 上海艳紫化工科技有限公司 月桂酰赖氨酸丝滑洗发香波
DE102014203267A1 (de) 2014-02-24 2015-08-27 Beiersdorf Ag Reinigungszubereitungen aus natürlichen Komponenten für Haut und Haar
CN104958194A (zh) * 2015-03-04 2015-10-07 上海应用技术学院 一种含亚麻籽提取液的护发素及其制备方法
EP4108228A1 (fr) 2017-10-10 2022-12-28 The Procter & Gamble Company Composition d'hygiène personnelle transparente sans sulfate comprenant un sel inorganique faible
DE102017223233A1 (de) * 2017-12-19 2019-06-19 Henkel Ag & Co. Kgaa Oxidatives Haarfärbemittel mit reduzierter Haarschädigung und verbesserten Färbeeigenschaften
WO2019144348A1 (fr) 2018-01-25 2019-08-01 Beiersdorf Daily Chemical (Wuhan) Co. Ltd. Composition de coiffure contenant de l'huile d'onagre et son utilisation
WO2020092237A1 (fr) * 2018-10-29 2020-05-07 Lonza Ltd Composition de nettoyage et de conditionnement des cheveux
IT201800010025A1 (it) * 2018-11-05 2020-05-05 Simet S R L Procedimento per il trattamento superficiale di metalli mediante bagno chimico.
EP4069375A1 (fr) 2019-12-06 2022-10-12 The Procter & Gamble Company Composition sans sulfate avec dépôt amélioré de principe actif pour le cuir chevelu
CN110882185A (zh) * 2019-12-24 2020-03-17 优牌生物科技有限公司 一种不含防腐剂的牙膏及其制备方法
US11679065B2 (en) 2020-02-27 2023-06-20 The Procter & Gamble Company Compositions with sulfur having enhanced efficacy and aesthetics
MX2023005963A (es) 2020-12-04 2023-06-07 Procter & Gamble Composiciones para el cuidado del cabello que comprenden materiales de reduccion del mal olor.
CN112426375B (zh) * 2020-12-15 2023-02-17 金发拉比妇婴童用品股份有限公司 一种麦芽糖洗发水
DE102021109834A1 (de) 2021-04-19 2022-10-20 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung eingetragener Verein Zusammensetzung zur Desinfektion und für kosmetische Anwendungen
US11771635B2 (en) 2021-05-14 2023-10-03 The Procter & Gamble Company Shampoo composition
US11986543B2 (en) 2021-06-01 2024-05-21 The Procter & Gamble Company Rinse-off compositions with a surfactant system that is substantially free of sulfate-based surfactants
WO2024057247A1 (fr) * 2022-09-17 2024-03-21 Arjuna Natural Private Limited Formulation pour la stimulation de la croissance des cheveux et l'amélioration de leur qualité et son procédé de préparation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5136093A (en) 1991-02-06 1992-08-04 Smith Ronald J Quaternized panthenol compounds and their use
DE202005007603U1 (de) * 2005-05-13 2005-08-04 HD Health Development GmbH Zusammensetzung umfassend eine Kombination aus Arganöl und Schwarzkümmelöl
DE102005038359A1 (de) * 2005-08-11 2007-02-15 Henkel Kgaa Amaranthsamenöl in Haarbehandlungsmitteln

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
None *
See also references of WO2010026009A1 *

Also Published As

Publication number Publication date
WO2010026009A1 (fr) 2010-03-11
DE102008046207A1 (de) 2010-06-17

Similar Documents

Publication Publication Date Title
EP2317969A1 (fr) Produit de traitement capillaire
EP2313073B1 (fr) Système de tensioactif doux sans sulfates pour le nettoyage de la peau et des cheveux
DE102010043074A1 (de) Wirkstoffkombination und Haarbehandlungsmittel gegen Schuppen III
WO2010015517A2 (fr) Agent de lavage et de soin des cheveux contenant des ingrédients bioactifs
WO2009024359A1 (fr) Agents de traitement capillaire contenant une ou plusieurs substances de soin et mélatonine/agomélatine
DE102010030555A1 (de) Natürliches Haarbehandlungsmittel mit Leistungsverstärker I
WO2012055585A1 (fr) Combinaison d'actifs et agents pour traiter les cheveux contre les pellicules i
EP2271309A1 (fr) Shampooings à base de jus de fruits et/ou de légumes
EP2632417A1 (fr) Combinaison d'actifs et agents pour traiter les cheveux contre les pellicules ii
WO2013068172A2 (fr) Produits de soins capillaires
WO2009024360A1 (fr) Agents de traitement capillaire contenant un ou plusieurs tensioactifs et mélatonine/agomélatine
WO2012055588A1 (fr) Combinaison d'actifs et agents pour traiter les cheveux contre les pellicules iv
WO2009024361A1 (fr) Agents de traitement capillaire contenant un ou plusieurs alcools et de la mélatonine/agomélatine
EP2841169B1 (fr) Produit de traitement capillaire contenant un (des) organopolysiloxane(s) à terminaison hydroxy et un (des) agent(s) épaississant(s)
WO2012076280A2 (fr) Association de principes actifs et agent de traitement capillaire
EP2214631B1 (fr) Produits d'hygiène capillaire contenant une association de tensioactifs et d'épaississants
WO2012055584A2 (fr) Agents de traitement capillaire comprenant du 3-méthyl-1,3-butanediol et un/des alkylpolyglycoside(s)
DE102010030554A1 (de) Natürliches Haarbehandlungsmittel mit Leistungsverstärker II
DE102007062520A1 (de) Haarreinigungsmittel mit Strukturantien
DE102010043067A1 (de) Haarbehandlungsmittel mit-3-Methyl-1,3-Butandiol und Amphotensid(en)
EP2734181A2 (fr) Agent de traitement capillaire tensioactif contenant de la poly-l-lysine ii
DE102007062521A1 (de) Stabilisierung von Haarreinigungssmitteln
WO2012055583A2 (fr) Agents de traitement capillaire comprenant du 3-méthyl-1,3-butanediol et un/des tensioactif(s) anioniques(s)
DE102008016218A1 (de) Haarreinigungsmittel mit Pflanzenextrakten
DE102011086537A1 (de) Pflegende Haarbehandlungsmittel

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20101214

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

AX Request for extension of the european patent

Extension state: AL BA RS

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20140219

REG Reference to a national code

Ref country code: DE

Ref legal event code: R003

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20180202